• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估使用气动吸入器AMSA治疗咽鼓管功能障碍的有效性。

Assesment effectiveness of treatment Eustachian tube dysfunction using pneumatic inhaler AMSA.

作者信息

Zając-Ratajczak Iwona, Szkiełkowska Agata, Wilhelmsen Karina

出版信息

Otolaryngol Pol. 2016 Nov 20;70(6):6-11. doi: 10.5604/01.3001.0009.3737.

DOI:10.5604/01.3001.0009.3737
PMID:28485286
Abstract

INTRODUCTION

Upper respiratory tract infections are common childhood diseases. Children are more susceptible to middle ear infections because their Eustachian tube is short, straight and wide. As a consequence of these inflammatory changes while impaired patency of the Eustachian tube often arises conductive hearing.

OBJECTIVE

The aim of this study was to Assessment effectiveness of treatment Eustachian tube dysfunction using inhaler AMSA.

MATERIAL AND METHODS

The study group comprised 30 patients. Same was in the control group. All patients reported conductive hearing loss. Test group was treated as an inhaler AMSA. The control group was treated pharmacologically. Patients were examined with the use of pure-tone audiometry, and impedance at baseline, after one week and four weeks.

RESULTS

Statistical analysis showed improvement in the studied parameters in patients treated with inhaler AMSA in a much shorter time than patients treated with pharmacotherapy.

摘要

引言

上呼吸道感染是常见的儿童疾病。儿童更容易患中耳感染,因为他们的咽鼓管短、直且宽。这些炎症变化的结果是,咽鼓管通畅受损时常常会出现传导性听力损失。

目的

本研究的目的是评估使用AMSA吸入器治疗咽鼓管功能障碍的有效性。

材料与方法

研究组包括30名患者。对照组也是30名患者。所有患者均报告有传导性听力损失。试验组使用AMSA吸入器进行治疗。对照组采用药物治疗。在基线、一周后和四周后,使用纯音听力计和阻抗对患者进行检查。

结果

统计分析表明,使用AMSA吸入器治疗的患者,其研究参数的改善时间比药物治疗的患者短得多。

相似文献

1
Assesment effectiveness of treatment Eustachian tube dysfunction using pneumatic inhaler AMSA.评估使用气动吸入器AMSA治疗咽鼓管功能障碍的有效性。
Otolaryngol Pol. 2016 Nov 20;70(6):6-11. doi: 10.5604/01.3001.0009.3737.
2
[Evaluation of the level of hearing loss based on the results of tympanometry in children under 5 years of age with eustachian tube dysfunction].[基于咽鼓管功能障碍的5岁以下儿童鼓室图结果评估听力损失程度]
Med Pregl. 2000 Nov-Dec;53(11-12):559-63.
3
[Function of the eustachian tube and the middle ear in lymphoproliferative diseases].[咽鼓管及中耳在淋巴增生性疾病中的作用]
Cesk Otolaryngol. 1985 Sep;34(5):286-93.
4
Efficacy of balloon dilation in the treatment of symptomatic Eustachian tube dysfunction: One year follow-up study.球囊扩张术治疗症状性咽鼓管功能障碍的疗效:一年随访研究
Am J Otolaryngol. 2016 Mar-Apr;37(2):99-102. doi: 10.1016/j.amjoto.2015.10.010. Epub 2015 Nov 11.
5
[Physiotherapy of Eustachian tube dysfunction in adults--preliminary report].[成人咽鼓管功能障碍的物理治疗——初步报告]
Otolaryngol Pol. 2003;57(2):277-81.
6
[Conductive hearing loss caused by eustachian tube dysfunction according to the data of functional computed tomography].[根据功能性计算机断层扫描数据分析咽鼓管功能障碍所致传导性听力损失]
Vestn Rentgenol Radiol. 2012 Jan-Feb(1):4-8.
7
Promising results after balloon dilatation of the Eustachian tube for obstructive dysfunction.咽鼓管球囊扩张术治疗阻塞性功能障碍取得了有前景的结果。
Dan Med J. 2014 Apr;61(4):A4818.
8
Effects of semirapid maxillary expansion on conductive hearing loss.上颌骨半快速扩弓对传导性听力损失的影响。
Am J Orthod Dentofacial Orthop. 2008 Jun;133(6):846-51. doi: 10.1016/j.ajodo.2006.05.047.
9
Hearing and otopathology in Apert syndrome.Apert综合征的听力与耳病理学
Arch Otolaryngol. 1982 Jun;108(6):347-9. doi: 10.1001/archotol.1982.00790540019006.
10
[Changes in transitory evoked otoacoustic emissions and acoustic distortion products in disorders of eustachian tube ventilation].[咽鼓管通气障碍时瞬态诱发性耳声发射及畸变产物耳声发射的变化]
HNO. 1994 Jul;42(7):434-40.

引用本文的文献

1
Resolution of Otitis Media with Effusion in Adults after a Three-Day Course of Treatment with a Manosonic Nebulizer-A Pilot Study.成人经三天 manoSONIC 雾化器治疗后分泌性中耳炎的疗效观察——一项初步研究。
Medicina (Kaunas). 2023 Jan 19;59(2):201. doi: 10.3390/medicina59020201.